支持本港應對疫情，包括盡快引入安全、有效的疫苗及診斷測試。
最新消息
GBA Training 2020
一月 14, 2021
The Greater Bay Area development has taken centre stage in Hong Kong Policy Address 2020. To facilitate members taking business…
7 Medical Representatives Got Distinction in HKAPI Medical Representatives Training Programme 2020
十二月 24, 2020
The HKAPI Medical Representatives Training Programme has been completed in 2020 with all classes being done online during this era…
HKAPI Virtual Engagement Guidance
十一月 4, 2020
In its Extraordinary General Meeting held on 4 November 2020, the HKAPI has passed a motion to adopt a set…
World Rare Disease Day 2020 Online Symposium
十月 17, 2020
Our task force leads Karen Yuen and Sui Wong joined the “World Rare Disease Day 2020 Online Symposium” organized by…
Senior Executive Director takes top honour at APEC 2020 Lighthouse Award
十月 13, 2020
Sabrina Chan So Kuen, Senior Executive Director of Hong Kong Association of Pharmaceutical Industry, has been awarded APEC 2020 Lighthouse…
香港科研製藥聯會就2020年《施政報告》提出的政策建議（只備英文本）
九月 2, 2020
The Hong Kong Association of the Pharmaceutical Industry (HKAPI) submits this opinion paper, on behalf of its 33 member companies…
有用資料
常用網站及資訊
實務守則
助會員公司處理業務時恪守誠信及道德
藥物資助計劃
為醫護人員而設的藥物資助計劃資訊一站式平台
立場書
本會就醫療健康政策發表的意見
關於香港科研製藥聯會
以高專業道德標準，推動創新醫療方案的引入，讓香港及澳門市民受惠。
香港科研製藥聯會 創立於1968年，目前共有33個基本會員，所有會員皆屬跨國性的科研藥品生產商，當中包括名列全球首二十間藥廠。本會會員供應的藥品佔全港治療性藥品百份之七十以上。
本會致力就醫療政策及制度提出意見，包括就施政報告、財政預算案、自願醫保計劃、《2015年藥劑業及毒藥(修訂)條例草案及藥物相關法規提交政策建議，以促進香港市民的健康。
Get in touch
Please fill in the following information for further inquiries.
地址：香港北角渣華道191號嘉華國際中心9樓906-7室
電話：2528-3061
傳真：2865-6283
電郵地址：[email protected]
